- Trade stocks for $0 and no annual fee
- Start trading with a $0 minimum deposit
- Get up to $1,000 when you fund a new account within 30 days
Tivity Health is a health care providers & services business based in the US. Tivity Health shares (TVTY) are listed on the NASDAQ and all prices are listed in US Dollars. Tivity Health employs 380 staff and has a trailing 12-month revenue of around $500.7 million.
|Latest market close||$32.50|
|52-week range||$24.38 - $32.89|
|50-day moving average||$32.16|
|200-day moving average||$28.08|
|Wall St. target price||$27.00|
|Dividend yield||$0 (0%)|
|Earnings per share (TTM)||$1.71|
Information on this page is for educational purposes only. Finder is not an advisor or brokerage service, and we don't recommend investors to trade specific stocks or other investments.
Finder is not a client of any featured partner. We may be paid a fee for referring prospective clients to a partner, though it is not a recommendation to invest in any one partner.
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.
|1 week (2023-01-28)||N/A|
|1 month (2023-01-04)||N/A|
|3 months (2022-11-04)||N/A|
|6 months (2022-08-04)||N/A|
|1 year (2022-02-08)||25.77%|
|2 years (2021-02-08)||33.36%|
|3 years (2020-02-07)||44.19%|
|5 years (2018-02-08)||36.2|
Valuing Tivity Health stock is incredibly difficult, and any metric has to be viewed as part of a bigger picture of Tivity Health's overall performance. However, analysts commonly use some key metrics to help gauge the value of a stock.
Tivity Health's current share price divided by its per-share earnings (EPS) over a 12-month period gives a "trailing price/earnings ratio" of roughly 19x. In other words, Tivity Health shares trade at around 19x recent earnings.
That's relatively low compared to, say, the trailing 12-month P/E ratio for the NASDAQ 100 at the end of 2019 (27.29). The low P/E ratio could mean that investors are pessimistic about the outlook for the shares or simply that they're under-valued.
Tivity Health's "price/earnings-to-growth ratio" can be calculated by dividing its P/E ratio by its growth – to give 1.8445. A low ratio can be interpreted as meaning the shares offer better value, while a higher ratio can be interpreted as meaning the shares offer worse value.
The PEG ratio provides a broader view than just the P/E ratio, as it gives more insight into Tivity Health's future profitability. By accounting for growth, it could also help you if you're comparing the share prices of multiple high-growth companies.
Tivity Health's EBITDA (earnings before interest, taxes, depreciation and amortisation) is $150.6 million.
The EBITDA is a measure of a Tivity Health's overall financial performance and is widely used to measure a its profitability.
|Revenue TTM||$500.7 million|
|Operating margin TTM||27.73%|
|Gross profit TTM||$203 million|
|Return on assets TTM||15.29%|
|Return on equity TTM||114.24%|
|Market capitalisation||$1.6 billion|
TTM: trailing 12 months
We're not expecting Tivity Health to pay a dividend over the next 12 months.
Tivity Health's shares were split on a 2:1 basis on 21 December 2003. So if you had owned 1 share the day before before the split, the next day you'd have owned 2 shares. This wouldn't directly have changed the overall worth of your Tivity Health shares – just the quantity. However, indirectly, the new 50% lower share price could have impacted the market appetite for Tivity Health shares which in turn could have impacted Tivity Health's share price.
Over the last 12 months, Tivity Health's shares have ranged in value from as little as $24.38 up to $32.89. A popular way to gauge a stock's volatility is its "beta".
Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while Tivity Health's is 2.1411. This would suggest that Tivity Health's shares are significantly more volatile than the average for this exchange and represent a higher risk.
Tivity Health, Inc. provides fitness and health products and solutions in the United States. The company offers SilverSneakers to members of Medicare Advantage, Medicare Supplement, and group retiree plans; Prime Fitness, a fitness facility access program through commercial health plans, employers, and other sponsoring organizations; virtual fitness experiences, including live instructor-led classes; and WholeHealth living program, a continuum of services related to complementary, alternative, and physical medicine. It also provides Wisely Well brand meals designed to support individuals and caregivers who are seeking meal convenience, as well as those recovering after a hospitalization or living with chronic conditions. The company was formerly known as Healthways, Inc. and changed its name to Tivity Health, Inc. in January 2017.
Everything we know about the Neuraxis IPO, plus information on how to buy in.
Everything we know about the TXO Energy IPO, plus information on how to buy in.
Everything we know about the Brera IPO, plus information on how to buy in.
What you need to know about investing in the leading indicator for the overall US stock market.
Buying an IPO is as simple as buying any other stock, but not every trading platform offers IPO stocks.
Steps to owning and managing NVOS, with 24-hour and historical pricing before you buy.
Your simple and straightforward guide to ETFs, how they work and the different types available.
Find out how stock lending works, the extra income you could potentially earn and the risks you should be aware of. Plus, compare stock trading platforms that offer stock lending.
Everything we know about the SONDORS IPO, plus information on how to buy in.
Everything we know about the Bullfrog AI Holdings IPO, plus information on how to buy in.
finder.com is an independent comparison platform and information service that aims to provide you with the tools you need to make better decisions. While we are independent, the offers that appear on this site are from companies from which finder.com receives compensation. We may receive compensation from our partners for placement of their products or services. We may also receive compensation if you click on certain links posted on our site. While compensation arrangements may affect the order, position or placement of product information, it doesn't influence our assessment of those products. Please don't interpret the order in which products appear on our Site as any endorsement or recommendation from us. finder.com compares a wide range of products, providers and services but we don't provide information on all available products, providers or services. Please appreciate that there may be other options available to you than the products, providers or services covered by our service.